Aktekin, Mine BugaOksuz, ZehraTurkmenoglu, BurcinIstifli, Erman SalihKuzucu, MehmetAlgul, Oztekin2025-03-172025-03-1720241747-02771747-0285https://doi.org/10.1111/cbdd.14601https://hdl.handle.net/20.500.13099/1783Cumulative escalation in antibiotic-resistant pathogens necessitates the quest for novel antimicrobial agents, as current options continue to diminish bacterial resistance. Herein, we report the synthesis of di-heterocyclic benzazole structures (12-19) and their in vitro evaluation for some biological activities. Compounds 16 and 17 demonstrated potent antibacterial activity (MIC = 7.81 mu g/mL) against Staphylococcus aureus, along with significant anti-biofilm activity. Noteworthy is the capability of Compound 17 to inhibit biofilm formation by at least 50% at sub-MIC (3.90 mu g/mL) concentration. Furthermore, both compounds exhibited the potential to inhibit preformed biofilm by at least 50% at the MIC concentration (7.81 mu g/mL). Additionally, Compounds 16 and 17 were examined for cytotoxic effects in HFF-1 cells, using the MTT method, and screened for binding interactions within the active site of S. aureus DNA gyrase using in silico molecular docking technique, employing AutoDock 4.2.6 and Schr & ouml;dinger Glidse programs. Overall, our findings highlight Compounds 16 and 17 as promising scaffolds warranting further optimization for the development of effective antibacterial and anti-biofilm agents.eninfo:eu-repo/semantics/openAccessanti-biofilm activityantimicrobialcytotoxicitydi-heterocyclic benzazolemolecular dockingsynthesisArticle10.1111/cbdd.146011042Q2WOS:0012814512000012-s2.0-8520015462639085984Q2